$1.5 Billion AI-based Clinical Trials Market 2026-2032: Rising Investment from Biopharma Sponsors and CROs

Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "AI-based Clinical Trials Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

The AI-based clinical trials market is driving a fundamental transformation in how life sciences organizations gather evidence, ensure patient safety, and enhance operational resilience. Senior decision-makers are witnessing the pivotal role of artificial intelligence in modernizing clinical research and improving outcomes across the development lifecycle.

Market Snapshot

The AI-based Clinical Trials Market expanded from USD 1.42 billion in 2025 to USD 1.49 billion in 2026 and is projected to maintain robust growth at a CAGR of 5.97%, ultimately reaching USD 2.13 billion by 2032. This trajectory reflects rising adoption of AI in protocol design, study execution, and safety oversight while responding to evolving regulatory and operational demands. The market's progression is marked by increasing investment from biopharma sponsors and CROs as innovation and regulatory reform converge with expanding data sources.

Scope & Segmentation

• Components: Services (including consulting, data management, implementation, maintenance, and operations) and Software AG Solutions (covering AI-driven monitoring, predictive analytics, and data management tools).
• Technologies: Computer vision, deep learning, classical machine learning, and natural language processing, each applied to different data types and analytic needs.
• Deployment Modes: Cloud-based, on-premise, and hybrid architectures, enabling scalable solutions and customized data control.
• Study Phases: Support for early- to late-phase trials, from safety signal detection to protocol optimization and real-world evidence generation.
• Therapeutic Areas: Relevant across cardiology, endocrinology, infectious disease, neurology, and oncology, driven by varying data demands and regulatory focus.
• Applications: Data analysis and interpretation, compliance, patient recruitment, predictive modeling, safety monitoring, and trial design optimization.
• End Users: Academic and research institutes, biotechnology companies, contract research organizations, hospitals and clinics, pharmaceutical companies.
• Regions: Americas, Europe, Middle East & Africa, Asia-Pacific, each with unique adoption drivers, regulatory context, and clinical infrastructure.

Key Takeaways from This Report

• Artificial intelligence enables real-time data interpretation and accelerates evidence generation by integrating diverse clinical data, such as imaging and health records, into actionable insights.
• Cross-disciplinary collaboration among data science, clinical operations, IT, and regulatory teams is essential for seamless AI adoption and ensuring analytic outputs support critical trial decisions.
• Evolving patient expectations for convenience and transparency are shaping digital recruitment, remote assessments, and privacy-preserving model deployment strategies.
• Multimodal AI models, leveraging various data sources and advanced analytics, are driving richer clinical insights while requiring upgraded governance and model validation frameworks.
• Strong partnerships with regional technology vendors and CROs facilitate resilient implementation and compliance with local regulatory requirements.
• Strategic behavioral traits among leading players include validated model development, investment in modular architectures, and transparent reporting aligned with regulatory standards.
• Enables strategic planning by connecting market trends, regulatory dynamics, and technology evolution, while delivering actionable segmentation insights to support tailored technology investment, procurement, and deployment strategies.

Key Attributes

Key Topics Covered

1. Preface

2. Research Methodology

3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter's Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost- Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. AI-based Clinical Trials Market, by Component
8.1. Services
8.1.1. Consulting Services
8.1.2. Data Management
8.1.3. Implementation Services
8.1.4. Maintenance Services
8.1.5. Operational Services
8.2. Software AG Solutions
8.2.1. AI-based Monitoring Systems
8.2.2. Data Management Systems
8.2.3. Predictive Analytics Tools

9. AI-based Clinical Trials Market, by AI Technology
9.1. Computer Vision
9.2. Deep Learning
9.3. Machine Learning
9.4. Natural Language Processing

10. AI-based Clinical Trials Market, by Study Phase
10.1. Phase 1
10.2. Phase 2
10.3. Phase 3
10.4. Phase 4

11. AI-based Clinical Trials Market, by Deployment Mode
11.1. Cloud-based
11.2. On-premise

12. AI-based Clinical Trials Market, by Therapeutic Area
12.1. Cardiology
12.2. Endocrinology
12.3. Infectious Diseases
12.4. Neurology
12.5. Oncology

13. AI-based Clinical Trials Market, by Application
13.1. Data Analysis & Interpretation
13.2. Documentation & Compliance
13.3. Patient Recruitment & Enrollment
13.4. Predictive Modeling
13.5. Safety Monitoring
13.6. Trial Design Optimization

14. AI-based Clinical Trials Market, by End-Users
14.1. Academic & Research Institutions
14.2. Biotechnology Companies
14.3. Contract Research Organizations (CROs)
14.4. Hospitals & Clinics
14.5. Pharmaceutical Companies

15. AI-based Clinical Trials Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific

16. AI-based Clinical Trials Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO

17. AI-based Clinical Trials Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea

18. United States AI-based Clinical Trials Market

19. China AI-based Clinical Trials Market

20. Competitive Landscape
20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. AiCure, LLC
20.6. Aiforia Technologies Oyj
20.7. Antidote Technologies, Inc.
20.8. Avantor, Inc. by Audax Management Company, LLC
20.9. BioAge Labs, Inc.
20.10. BioSymetrics Inc.
20.11. Envisagenics
20.12. Euretos BV
20.13. Exscientia PLC by Recursion Pharmaceuticals
20.14. Alphabet LLC by Alphabet Inc.
20.15. Innoplexus AG
20.16. InSilico Medicine
20.17. Intel
20.18. IBM Corporation
20.19. Philips N.V.
20.20. Median Technologies SA
20.21. Nuritas Limited
20.22. Pharmaceutical Pipeline Enhancement Strategies, LLC
20.23. Saama Technologies, LLC
20.24. Selvita S.A.
20.25. symplr Software AG LLC
20.26. Tempus AI, Inc.
20.27. Trials.ai, Inc. by ZS Associates, Inc.
20.28. Unlearn.AI, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/olz3j3

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• AI-based Clinical Trials Market

CONTACT: 
CONTACT: ResearchAndMarkets.com 
         Laura Wood, Senior  Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900